MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12889-022-13464-7

Медицинская библиотека · BMC public health · 2022

Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.

Zamani Mohammad, Poustchi Hossein, Mohammadi Zahra, Dalvand Sahar, Sharafkhah Maryam, Motevalian Seyed Abbas, Eslami Saeid, Emami Amir, Somi Mohammad Hossein, Yazdani-Charati Jamshid, Saki Nader, Karami Manoochehr, Najafi Farid, Mohebbi Iraj, Veisi Nasrollah, Hormati Ahmad, Pourfarzi Farhad, Ghadimi Reza, Ansari-Moghaddam Alireza, Sharifi Hamid, Roshandel Gholamreza, Mansour-Ghanaei Fariborz, Joukar Farahnaz, Shayanrad Amaneh, Eghtesad Sareh, Niavarani Ahmadreza, Delavari Alireza, Kaveh Soudeh, Feizesani Akbar, Markarian Melineh, Shafighian Fatemeh, Sadjadi Alireza, Darvishian Maryam, Malekzadeh Reza

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence of 17.1% among the general population in the first wave of the epidemic by April, 2020. The purpose of the current study was to assess the seroprevalence of COVID-19 infection among Iranian general population after the third wave of the disease.

METHODS

This population-based cross-sectional study was conducted on 7411 individuals aged ≥10 years old in 16 cities across 15 provinces in Iran between January and March, 2021. We randomly sampled individuals registered in the Iranian electronic health record system based on their national identification numbers and invited them by telephone to a healthcare center for data collection. Presence of SARS-CoV-2-specific IgG and IgM antibodies was assessed using the SARS-CoV-2 ELISA kits. The participants were also asked about their recent COVID-19-related symptoms, including cough, fever, chills, sore throat, headache, dyspnea, diarrhea, anosmia, conjunctivitis, weakness, myalgia, arthralgia, altered level of consciousness, and chest pain. The seroprevalence was estimated after adjustment for population weighting and test performance.

RESULTS

The overall population-weighted seroprevalence adjusted for test performance was 34.2% (95% CI 31.0-37.3), with an estimated 7,667,874 (95% CI 6,950,412-8,362,915) infected individuals from the 16 cities. The seroprevalence varied between the cities, from the highest estimate in Tabriz (39.2% [95% CI 33.0-45.5]) to the lowest estimate in Kerman (16.0% [95% CI 10.7-21.4]). In the 16 cities studied, 50.9% of the seropositive individuals did not report a history of symptoms suggestive of COVID-19, implying an estimation of 3,902,948 (95% CI 3,537,760-4,256,724) asymptomatic infected individuals.

CONCLUSIONS

Nearly one in three individuals were exposed to SARS-CoV-2 in the studied cities by March 2021. The seroprevalence increased about two-fold between April, 2020, and March, 2021.

Для цитирования: Zamani Mohammad, Poustchi Hossein, Mohammadi Zahra, Dalvand Sahar, Sharafkhah Maryam, Motevalian Seyed Abbas, Eslami Saeid, Emami Amir, Somi Mohammad Hossein, Yazdani-Charati Jamshid, Saki Nader, Karami Manoochehr, Najafi Farid, Mohebbi Iraj, Veisi Nasrollah, Hormati Ahmad, Pourfarzi Farhad, Ghadimi Reza, Ansari-Moghaddam Alireza, Sharifi Hamid, Roshandel Gholamreza, Mansour-Ghanaei Fariborz, Joukar Farahnaz, Shayanrad Amaneh, Eghtesad Sareh, Niavarani Ahmadreza, Delavari Alireza, Kaveh Soudeh, Feizesani Akbar, Markarian Melineh, Shafighian Fatemeh, Sadjadi Alireza, Darvishian Maryam, Malekzadeh Reza. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.. BMC public health. 2022. DOI: 10.1186/s12889-022-13464-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.